-
Mashup Score: 1Online Event - 3 month(s) ago
We now know that cancer cells are not all alike, even within the same tumor mass, and that numerous types of normal cells are coopted to create a unique tumor microenvironment. Single-cell RNA sequencing (scRNAseq) is a powerful tool used for characterizing the individual transcriptional landscape of thousands of individual cells simultaneously. This method not only facilitates precise identification of cell types but also uncovers intracellular signaling pathways and intercellular communication.
Source: www.workcast.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4Online Event - 3 month(s) ago
We now know that cancer cells are not all alike, even within the same tumor mass, and that numerous types of normal cells are coopted to create a unique tumor microenvironment. Single-cell RNA sequencing (scRNAseq) is a powerful tool used for characterizing the individual transcriptional landscape of thousands of individual cells simultaneously. This method not only facilitates precise identification of cell types but also uncovers intracellular signaling pathways and intercellular communication.
Source: www.workcast.comCategories: General Medicine News, General NewsTweet-
Tomorrow: Webinar on single-cell RNA sequencing in cancer March 18 | 12:00 p.m. ET Join David Coffey (@SylvesterCancer), Ryan Roberts (@nationwidekids), & Emil Lou (@UMNews) to explore how #scRNAseq is shaping the future of cancer research. Register: https://t.co/pZrlj9R0dq https://t.co/srnx8W5ZF6
-
-
Mashup Score: 17Online Event - 3 month(s) ago
We now know that cancer cells are not all alike, even within the same tumor mass, and that numerous types of normal cells are coopted to create a unique tumor microenvironment. Single-cell RNA sequencing (scRNAseq) is a powerful tool used for characterizing the individual transcriptional landscape of thousands of individual cells simultaneously. This method not only facilitates precise identification of cell types but also uncovers intracellular signaling pathways and intercellular communication.
Source: www.workcast.comCategories: General Medicine News, Oncologists1Tweet-
Tomorrow: Webinar on single-cell RNA sequencing in cancer March 18 | 12:00 p.m. ET Join David Coffey (@SylvesterCancer), Ryan Roberts (@nationwidekids), & Emil Lou (@UMNews) to explore how #scRNA-seq is shaping the future of cancer research. https://t.co/eM5iWMPX0G https://t.co/inUNXXtUhy
-
-
Mashup Score: 5Online Event - 3 month(s) ago
We now know that cancer cells are not all alike, even within the same tumor mass, and that numerous types of normal cells are coopted to create a unique tumor microenvironment. Single-cell RNA sequencing (scRNAseq) is a powerful tool used for characterizing the individual transcriptional landscape of thousands of individual cells simultaneously. This method not only facilitates precise identification of cell types but also uncovers intracellular signaling pathways and intercellular communication.
Source: www.workcast.comCategories: General Medicine News, Allergy-ImmunologyTweet-
Tomorrow: Webinar on single-cell RNA sequencing in cancer March 18 | 12:00 p.m. ET Join David Coffey (@SylvesterCancer), Ryan Roberts (@nationwidekids), & Emil Lou (@UMNews) to explore how #scRNA-seq is shaping the future of cancer research. https://t.co/ZOzXCX0PVz https://t.co/qUA8q0QMMV
-
-
Mashup Score: 6Online Event - 5 month(s) ago
Traditionally, test developers have used quantitative PCR (qPCR) to create highly specific laboratory-developed tests (LDTs). However, digital PCR (dPCR) is emerging as the preferred technology for newer LDTs because it provides absolute nucleic acid quant ification and greater precision than qPCR. While LDTs that use these methods must meet similar criteria and standards, there are technological differences that can have implications for validating dPCR-based tests. In this GEN webinar, Kathleen Davis,
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet-
LAST CHANCE! TODAY, Kathleen Davis, Associate Director of Operations at iCura Diagnostics, will describe her experience with validating a highly sensitive dPCR-based LDT for detecting low-frequency BRAF V600E mutations. REGISTER: https://t.co/Fi9w6jRRvN @QIAGEN #Cancer https://t.co/TZoqWcJLe0
-
-
Mashup Score: 6Online Event - 5 month(s) ago
Traditionally, test developers have used quantitative PCR (qPCR) to create highly specific laboratory-developed tests (LDTs). However, digital PCR (dPCR) is emerging as the preferred technology for newer LDTs because it provides absolute nucleic acid quant ification and greater precision than qPCR. While LDTs that use these methods must meet similar criteria and standards, there are technological differences that can have implications for validating dPCR-based tests. In this GEN webinar, Kathleen Davis,
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet-
DON'T MISS OUT! On 1/24, Kathleen Davis, Associate Director of Operations at iCura Diagnostics, will describe her experience with validating a highly sensitive dPCR-based LDT for detecting low-frequency BRAF V600E mutations. REGISTER: https://t.co/8mauHs67dT @QIAGEN #Cancer https://t.co/OHX3A0jWwF
-
-
Mashup Score: 12Online Event - 5 month(s) ago
If you’ve already registered, please click here to log in to the webcast. Join us for a webinar in which leaders of HTAN, Li Ding (Washington University St Louis), Ken Lau (Vanderbilt University) and Shannon Hughes (US National Cancer Institute) discuss the latest exciting progress from HTAN. Chaired by Alexia-Ileana Zaromytidou (Chief Editor, Nature Cancer), the discussions will provide insight into HTAN’s collaborations to compile detailed atlases integrating cellular, molecular and histological
Source: www.workcast.comCategories: General Medicine News, General HCPsTweet-
Join us for a webinar in which leaders of the Human Tumor Atlas Network will discuss their latest research that was published across Nature Portfolio journals and the work ahead. Register here: https://t.co/RCu5yLAX6J Browse the collection: https://t.co/8dP7Xq7G2b https://t.co/ljsPCe0JQ0
-
-
Mashup Score: 8Online Event - 6 month(s) ago
Traditionally, test developers have used quantitative PCR (qPCR) to create highly specific laboratory-developed tests (LDTs). However, digital PCR (dPCR) is emerging as the preferred technology for newer LDTs because it provides absolute nucleic acid quantification and gr eater precision than qPCR. While LDTs that use these methods must meet similar criteria and standards, there are technological differences that can have implications for validating dPCR-based tests. In this GEN webinar, Kathleen Davis,
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet-
NEW WEBINAR! On 1/24, Kathleen Davis, Associate Director of Operations at iCura Diagnostics, will describe her experience with validating a highly sensitive dPCR-based LDT for detecting low-frequency BRAF V600E mutations. REGISTER: https://t.co/T48tfNTvCl @QIAGEN #Cancer https://t.co/gubNk2pDuL
-
-
Mashup Score: 12Online Event - 6 month(s) ago
If you’ve already registered, please click here to log in to the webcast. Join us for a webinar in which leaders of HTAN, Li Ding (Washington University St Louis), Ken Lau (Vanderbilt University) and Shannon Hughes (US National Cancer Institute) discuss the latest exciting progress from HTAN. Chaired by Alexia-Ileana Zaromytidou (Chief Editor, Nature Cancer), the discussions will provide insight into HTAN’s collaborations to compile detailed atlases integrating cellular, molecular and histological
Source: www.workcast.comCategories: General Medicine News, General HCPsTweet-
Join us for a webinar in which leaders of the Human Tumor Atlas Network will discuss their latest research that was published across Nature Portfolio journals and the work ahead. Register here: https://t.co/RCu5yLAX6J Browse the collection: https://t.co/8dP7Xq7G2b https://t.co/ljsPCe0JQ0
-
-
Mashup Score: 8Online Event - 6 month(s) ago
Image credit: Claire Agosti/SayoStudio; Concept: Ania Hupalowska If you’ve already registered, please click here to log in to the webcast. Sarah Teichmann and Aviv Regev, co-founders of the Human Cell Atlas, discuss the latest research from the consortium, published by the Nature Portfolio as part of a new collection. They will provide insights on the importance of generating and analysing single-cell data from different tissues and developmental stages to build a Human Cell Atlas, as well as the opportunit
Source: www.workcast.comCategories: General Medicine News, General HCPsTweet-
Join us for a webinar with Sarah Teichmann and Aviv Regev, co-founders of the Human Cell Atlas, who will discuss the latest research that was published with Nature Portfolio. Register here: https://t.co/G7cIomTESe Browse the collection: https://t.co/50DI7syaYT https://t.co/NMaaIIjbzW
-
Today! Webinar on single-cell RNA sequencing in cancer Still time to join David Coffey (@SylvesterCancer), Ryan Roberts (@nationwidekids), & Emil Lou (@UMNews) as they discuss how #scRNA-seq is transforming cancer research. Register now: https://t.co/AB2AJVGU8n https://t.co/i2lN0SmvrD